Judgment of the General Court (Eighth Chamber) of 23 September 2020

BASF AS v European Commission

Medicinal products for human use – Marketing authorisation for medicinal products for human use containing omega-3 acid ethyl esters – Variation of the terms of the authorisation – First paragraph of Article 116 of Directive 2001/83/EC – Manifest error of assessment – Proportionality

Case T-472/19


Top of the page Documents in the Case
Document Date Name of the parties Subject-matter Curia EUR-Lex
Judgment (OJ)
30/10/2020 BASF v Commission
Judgment
ECLI:EU:T:2020:432
23/09/2020 BASF v Commission
EUR-Lex text EUR-Lex bilingual text
Judgment (Information)
ECLI:EU:T:2020:432
23/09/2020 BASF v Commission
Order (OJ)
25/10/2019 BASF v Commission
Application (OJ)
23/08/2019 BASF v Commission
Order
ECLI:EU:T:2019:555
19/08/2019 BASF v Commission
EUR-Lex text EUR-Lex bilingual text
Order (Information)
ECLI:EU:T:2019:555
19/08/2019 BASF v Commission
Top of the page Legal analysis of the decision or of the case

Reports of Cases

Not yet published (General Report - Section 'Information on unpublished decisions')

Subject-matter

Information not available

Systematic classification scheme

1.
4 Internal policy of the European Union
  4.11 Approximation of laws
    4.11.14 Pharmaceutical and cosmetic products
      4.11.14.01 Medicinal products for human use
        4.11.14.01.04 Marketing authorisation
          4.11.14.01.04.03 Amendment of authorisation
4 Internal policy of the European Union
  4.11 Approximation of laws
    4.11.14 Pharmaceutical and cosmetic products
      4.11.14.01 Medicinal products for human use
        4.11.14.01.04 Marketing authorisation
          4.11.14.01.04.03 Amendment of authorisation
4 Internal policy of the European Union
  4.11 Approximation of laws
    4.11.14 Pharmaceutical and cosmetic products
      4.11.14.01 Medicinal products for human use
        4.11.14.01.04 Marketing authorisation
          4.11.14.01.04.03 Amendment of authorisation
1 The legal order of the European Union
  1.07 Interpretation of EU law
1 The legal order of the European Union
  1.01 Sources of EU law
    1.01.02 General principles of law
      1.01.02.06 Principle of proportionality
4 Internal policy of the European Union
  4.11 Approximation of laws
    4.11.14 Pharmaceutical and cosmetic products
      4.11.14.01 Medicinal products for human use
        4.11.14.01.04 Marketing authorisation
          4.11.14.01.04.03 Amendment of authorisation
4 Internal policy of the European Union
  4.11 Approximation of laws
    4.11.14 Pharmaceutical and cosmetic products
      4.11.14.01 Medicinal products for human use
        4.11.14.01.04 Marketing authorisation
          4.11.14.01.04.03 Amendment of authorisation


Citations of case-law or legislation

References in grounds of judgment

Operative part

Information not available

Opinion

Information not available


Dates

Date of the lodging of the application initiating proceedings

  • 09/07/2019

Date of the Opinion

Information not available

Date of the hearing

Information not available

Date of delivery

23/09/2020


References

Publication in the Official Journal

Information not available

Name of the parties

BASF v Commission

Notes on Academic Writings

Information not available



Procedural Analysis Information

Source of the question referred for a preliminary ruling

Information not available

Subject-matter

  • Public health

Provisions of national law referred to

Information not available

Provisions of international law referred to

Information not available

Procedure and result

  • Actions for annulment : dismissal on substantive grounds

Formation of the Court

huitième chambre (Tribunal)

Judge-Rapporteur

Barents

Advocate General

Information not available

Language(s) of the Case

  • English

Language(s) of the Opinion

    Information not available